Guidance

Diabetic eye screening: optical coherence tomography in surveillance

Guidance for diabetic eye screening providers on use of optical coherence tomography (OCT) in surveillance clinics.

Applies to England

Documents

Details

This document provides consistent best practice guidance for diabetic eye screening (DES) services on the management of diabetic maculopathy in digital surveillance (DS) clinics using optical coherence tomography (OCT).

Updates to this page

Published 8 July 2020
Last updated 16 April 2025 show all updates
  1. Removed withdrawn optical coherence tomography (OCT) in diabetic eye screening (DES) surveillance clinics guidance. Removed PHE gateway reference numbers.

  2. Added clarification that publication was previously published by Public Health England.

  3. Removed PHE

  4. Updated guidance

  5. First published.

Sign up for emails or print this page